Airway diffusing capacity of nitric oxide and steroid therapy in asthma

Hye Won Shin, Christine M. Rose-Gottron, Dan M. Cooper, Robert L. Newcomb, Steven George

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Exhaled nitric oxide (NO) concentration is a noninvasive index for monitoring lung inflammation in diseases such as asthma. The plateau concentration at constant flow is highly dependent on the exhalation flow rate and the use of corticosteroids and cannot distinguish airway and alveolar sources. In subjects with steroid-naive asthma (n 8) or steroid-treated asthma (n = 12) and in healthy controls (n 24), we measured flow-independent NO exchange parameters that partition exhaled NO into airway and alveolar regions and correlated these with symptoms and lung function. The mean (±SD) maximum airway flux (pl/s) and airway tissue concentration [parts/billion (ppb)] of NO were lower in steroid-treated asthmatic subjects compared with steroid-naive asthmatic subjects (1,195 ± 836 pl/s and 143 ± 66 ppb compared with 2,693 ± 1,687 pl/s and 438 ± 312 ppb, respectively). In contrast, the airway diffusing capacity for NO (pl·s-1·ppb-1) was elevated in both asthmatic groups compared with healthy controls, independent of steroid therapy (11.8 ± 11.7, 8.71 ± 5.74, and 3.13 ± 1.57 pl·s -1·ppb-1 for steroid treated, steroid naive, and healthy controls, respectively). In addition, the airway diffusing capacity was inversely correlated with both forced expired volume in 1 s and forced vital capacity (%predicted), whereas the airway tissue concentration was positively correlated with forced vital capacity. Consistent with previously reported results from Silkoff et al. (Silkoff PE, Sylvester JT, Zamel N, and Permutt S, Am J Respir Crit Med 161: 1218-1228, 2000) that used an alternate technique, we conclude that the airway diffusing capacity for NO is elevated in asthma independent of steroid therapy and may reflect clinically relevant changes in airways.

Original languageEnglish (US)
Pages (from-to)65-75
Number of pages11
JournalJournal of Applied Physiology
Volume96
Issue number1
DOIs
StatePublished - Jan 1 2004

Fingerprint

Nitric Oxide
Asthma
Steroids
Vital Capacity
Therapeutics
Exhalation
Pneumonia
Adrenal Cortex Hormones
Lung

Keywords

  • Airways
  • Alveoli
  • Inflammation
  • Model

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Airway diffusing capacity of nitric oxide and steroid therapy in asthma. / Shin, Hye Won; Rose-Gottron, Christine M.; Cooper, Dan M.; Newcomb, Robert L.; George, Steven.

In: Journal of Applied Physiology, Vol. 96, No. 1, 01.01.2004, p. 65-75.

Research output: Contribution to journalArticle

Shin, Hye Won ; Rose-Gottron, Christine M. ; Cooper, Dan M. ; Newcomb, Robert L. ; George, Steven. / Airway diffusing capacity of nitric oxide and steroid therapy in asthma. In: Journal of Applied Physiology. 2004 ; Vol. 96, No. 1. pp. 65-75.
@article{cfb5a4fd3c764f1cbc3fff04194cf719,
title = "Airway diffusing capacity of nitric oxide and steroid therapy in asthma",
abstract = "Exhaled nitric oxide (NO) concentration is a noninvasive index for monitoring lung inflammation in diseases such as asthma. The plateau concentration at constant flow is highly dependent on the exhalation flow rate and the use of corticosteroids and cannot distinguish airway and alveolar sources. In subjects with steroid-naive asthma (n 8) or steroid-treated asthma (n = 12) and in healthy controls (n 24), we measured flow-independent NO exchange parameters that partition exhaled NO into airway and alveolar regions and correlated these with symptoms and lung function. The mean (±SD) maximum airway flux (pl/s) and airway tissue concentration [parts/billion (ppb)] of NO were lower in steroid-treated asthmatic subjects compared with steroid-naive asthmatic subjects (1,195 ± 836 pl/s and 143 ± 66 ppb compared with 2,693 ± 1,687 pl/s and 438 ± 312 ppb, respectively). In contrast, the airway diffusing capacity for NO (pl·s-1·ppb-1) was elevated in both asthmatic groups compared with healthy controls, independent of steroid therapy (11.8 ± 11.7, 8.71 ± 5.74, and 3.13 ± 1.57 pl·s -1·ppb-1 for steroid treated, steroid naive, and healthy controls, respectively). In addition, the airway diffusing capacity was inversely correlated with both forced expired volume in 1 s and forced vital capacity ({\%}predicted), whereas the airway tissue concentration was positively correlated with forced vital capacity. Consistent with previously reported results from Silkoff et al. (Silkoff PE, Sylvester JT, Zamel N, and Permutt S, Am J Respir Crit Med 161: 1218-1228, 2000) that used an alternate technique, we conclude that the airway diffusing capacity for NO is elevated in asthma independent of steroid therapy and may reflect clinically relevant changes in airways.",
keywords = "Airways, Alveoli, Inflammation, Model",
author = "Shin, {Hye Won} and Rose-Gottron, {Christine M.} and Cooper, {Dan M.} and Newcomb, {Robert L.} and Steven George",
year = "2004",
month = "1",
day = "1",
doi = "10.1152/japplphysiol.00575.2003",
language = "English (US)",
volume = "96",
pages = "65--75",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Airway diffusing capacity of nitric oxide and steroid therapy in asthma

AU - Shin, Hye Won

AU - Rose-Gottron, Christine M.

AU - Cooper, Dan M.

AU - Newcomb, Robert L.

AU - George, Steven

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Exhaled nitric oxide (NO) concentration is a noninvasive index for monitoring lung inflammation in diseases such as asthma. The plateau concentration at constant flow is highly dependent on the exhalation flow rate and the use of corticosteroids and cannot distinguish airway and alveolar sources. In subjects with steroid-naive asthma (n 8) or steroid-treated asthma (n = 12) and in healthy controls (n 24), we measured flow-independent NO exchange parameters that partition exhaled NO into airway and alveolar regions and correlated these with symptoms and lung function. The mean (±SD) maximum airway flux (pl/s) and airway tissue concentration [parts/billion (ppb)] of NO were lower in steroid-treated asthmatic subjects compared with steroid-naive asthmatic subjects (1,195 ± 836 pl/s and 143 ± 66 ppb compared with 2,693 ± 1,687 pl/s and 438 ± 312 ppb, respectively). In contrast, the airway diffusing capacity for NO (pl·s-1·ppb-1) was elevated in both asthmatic groups compared with healthy controls, independent of steroid therapy (11.8 ± 11.7, 8.71 ± 5.74, and 3.13 ± 1.57 pl·s -1·ppb-1 for steroid treated, steroid naive, and healthy controls, respectively). In addition, the airway diffusing capacity was inversely correlated with both forced expired volume in 1 s and forced vital capacity (%predicted), whereas the airway tissue concentration was positively correlated with forced vital capacity. Consistent with previously reported results from Silkoff et al. (Silkoff PE, Sylvester JT, Zamel N, and Permutt S, Am J Respir Crit Med 161: 1218-1228, 2000) that used an alternate technique, we conclude that the airway diffusing capacity for NO is elevated in asthma independent of steroid therapy and may reflect clinically relevant changes in airways.

AB - Exhaled nitric oxide (NO) concentration is a noninvasive index for monitoring lung inflammation in diseases such as asthma. The plateau concentration at constant flow is highly dependent on the exhalation flow rate and the use of corticosteroids and cannot distinguish airway and alveolar sources. In subjects with steroid-naive asthma (n 8) or steroid-treated asthma (n = 12) and in healthy controls (n 24), we measured flow-independent NO exchange parameters that partition exhaled NO into airway and alveolar regions and correlated these with symptoms and lung function. The mean (±SD) maximum airway flux (pl/s) and airway tissue concentration [parts/billion (ppb)] of NO were lower in steroid-treated asthmatic subjects compared with steroid-naive asthmatic subjects (1,195 ± 836 pl/s and 143 ± 66 ppb compared with 2,693 ± 1,687 pl/s and 438 ± 312 ppb, respectively). In contrast, the airway diffusing capacity for NO (pl·s-1·ppb-1) was elevated in both asthmatic groups compared with healthy controls, independent of steroid therapy (11.8 ± 11.7, 8.71 ± 5.74, and 3.13 ± 1.57 pl·s -1·ppb-1 for steroid treated, steroid naive, and healthy controls, respectively). In addition, the airway diffusing capacity was inversely correlated with both forced expired volume in 1 s and forced vital capacity (%predicted), whereas the airway tissue concentration was positively correlated with forced vital capacity. Consistent with previously reported results from Silkoff et al. (Silkoff PE, Sylvester JT, Zamel N, and Permutt S, Am J Respir Crit Med 161: 1218-1228, 2000) that used an alternate technique, we conclude that the airway diffusing capacity for NO is elevated in asthma independent of steroid therapy and may reflect clinically relevant changes in airways.

KW - Airways

KW - Alveoli

KW - Inflammation

KW - Model

UR - http://www.scopus.com/inward/record.url?scp=0347993718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347993718&partnerID=8YFLogxK

U2 - 10.1152/japplphysiol.00575.2003

DO - 10.1152/japplphysiol.00575.2003

M3 - Article

C2 - 12959957

AN - SCOPUS:0347993718

VL - 96

SP - 65

EP - 75

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 1

ER -